Newsletter | March 18, 2021

03.18.21 -- Biosimilar Regulatory And Legislative Actions Set Tone For 2021

Featured Editorial
Industry Insights
Is Your Biologic At Risk For Protein Aggregation? Part 3

The main culprit of a failing biologic drug is usually a flawed formulation. In this article, we cover formulation components and how they may affect protein aggregation. Part three of a three-part series.

Meeting The Process Development Challenges Of A Diverse Biologic Pipeline

The biopharmaceutical industry has been growing and evolving at a pace that’s hard to match, especially in terms of manufacturing. Understanding what challenges diverse molecules can create and how to manage these challenges is key to ensuring they reach patients safely and efficiently.  

Success At Speed: Best Practices To Accelerate Vaccine Development

This collection of articles documents each step in the vaccine development journey and how technology and partnerships make the difference in getting medicines to patients when they need them most.

News Headlines
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.